M&As this week: The Carlyle Group, Zecotek Photonics, Kypha

20 July 2018 (Last Updated July 20th, 2018 10:23)

The Carlyle Group has agreed to purchase a majority interest in LPG Systems.

The Carlyle Group has agreed to purchase a majority interest in LPG Systems.

The transaction is expected to close in the Q3 2018, subject to customary closing conditions and regulatory approvals.

Based in the US, The Carlyle Group operates as a private equity firm while LPG Systems is a France-based medical device company that manufactures aesthetics and physiotherapy devices.

The transaction is expected to support The Carlyle Group’s international growth plans.

Zecotek Photonics has sold a 2% interest in its subsidiary Zecotek Imaging Systems for C$2m ($1.52m).

Based in Canada, Zecotek Photonics is a photonics technology company that develops photodetectors and high-performance scintillation crystals for the medical industry, while Zecotek Imaging Systems is a Singapore-based manufacturer of photodetectors and data acquisition modules for imaging applications.

“Bruker Corporation has acquired JPK Instruments (JPK).”

The transaction enables Zecotek Photonics to start the manufacturing of solid-state micro-pixel avalanche photodiodes and transistors.

Kypha has completed an acquisition of Biosensia.

Kypha is a US-based medical diagnostic devices and solutions provider. The acquisition is part of the company’s commitment to assess and monitor immune status results in various settings, including acute hospital care and physician offices.

Based in Ireland, Biosensia is a diagnostics platform and contract development company that develops point-of-care platforms.

The transaction will expand Kypha’s product portfolio of immune status monitoring platforms.

Bruker Corporation has acquired JPK Instruments (JPK).

Based in the US, Bruker Corporation is a medical device company that manufactures scientific instruments for molecular research, while JPK is a Germany-based manufacturer of nano-analytical instruments.

The deal is expected to expand Bruker Corporation’s life science microscopy portfolio by adding mechano-biology measurements for emerging life science applications.

LS2 has acquired Letco Medical from Court Square Capital Partners.

Pepper Hamilton has been appointed as legal advisor for the transaction.

LS2 is a provider of end-to-end information technology (IT) business solutions, while Letco Medical is a compounding supplies and equipment provider.

All of the companies involved in the transaction are based in the US.